No products in the cart.
At Telostrand, we build solutions where the system falls short. Like many meaningful innovations, Telostrand Cloud began with a problem.
Our laboratory invested in infrastructure we were told would scale with us. When circumstances changed, we were left with a costly system we could no longer use. Instead of accepting the limitation, we reimagined the approach entirely.
From that moment, Telostrand Cloud was born — our patent-pending, empiric antimicrobial sensitivity and resistance intelligence platform.
Telostrand Cloud leverages standard nucleic acid amplification methods to identify pathogens present in a sample. It then applies a curated, medically peer-reviewed database of antimicrobial response data to generate clinically actionable insights on antibiotic sensitivity — without the delays of traditional culture-based methods.
Paired with our guaranteed 24-hour turnaround time, Telostrand Cloud transforms patient care by eliminating the typical 5–7 day wait associated with culture and sensitivity testing. Faster answers mean faster, more informed treatment decisions.
Today, Telostrand Cloud supports testing across:
- Urinary tract infections (UTIs)
- Sexually transmitted infections (STDs)
- Wound infections
For more information about Telostrand Cloud, our patent portfolio, or our laboratory services, please contact us at Cs@telostrand.com.